A61K 39/40
Bacterial
Official title: bacterial
A61K39/40 (Bacterial) appears on 313 US grants and 437 published applications in this corpus.
Search patents in A61K- Granted patents
- 313
- Published applications
- 437
- Assignees
- 231
- Inventors
- 778
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 2 |
| 2002 | 5 | 5 |
| 2003 | 1 | 11 |
| 2004 | 4 | 5 |
| 2005 | 4 | 6 |
| 2006 | 4 | 3 |
| 2007 | 1 | 6 |
| 2008 | 3 | 15 |
| 2009 | 5 | 5 |
| 2010 | 3 | 11 |
| 2011 | 8 | 9 |
| 2012 | 7 | 14 |
| 2013 | 9 | 29 |
| 2014 | 15 | 28 |
| 2015 | 19 | 34 |
| 2016 | 26 | 47 |
| 2017 | 21 | 25 |
| 2018 | 32 | 33 |
| 2019 | 26 | 39 |
| 2020 | 22 | 19 |
| 2021 | 16 | 22 |
| 2022 | 16 | 18 |
| 2023 | 10 | 18 |
| 2024 | 15 | 15 |
| 2025 | 12 | 10 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Clostridium difficile antigens25 Aug 2026US 12,714,742 B2MicroPharm Limited
- Proteins and immunizing compositions containing Klebsiella proteins and methods of use28 Jul 2026US 12,691,167 B2Vaxxinova US, Inc.
- Immunogenic trimers2 Jun 2026US 12,642,848 B2International AIDS Vaccine Initiative
- Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof2 Jun 2026US 12,643,941 B2Trellis Bioscience, LLC
- Immunogenic trimers21 Apr 2026US 12,605,441 B2International AIDS Vaccine Initiative
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Recombinant hiv env polypeptides and their use27 Aug 2026US 2026/0250331 A1International AIDS Vaccine Initiative
- Methods and means for the production of ig-like molecules20 Aug 2026US 2026/0242840 A1Merus N.V.
- Vaccine against klebsiella pneumoniae16 Jul 2026US 2026/0199445 A1Idorsia Pharmaceuticals Ltd
- Monoclonal antibodies that interfere with iron uptake16 Jul 2026US 2026/0201022 A1
Most cited
By later US patents
- Method for treating infectious respiratory diseases270US 5,290,540 AThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 1994
- Bacteria and immunoglobulin-containing composition for human gastrointestinal health67US 5,531,988 AMetagenics, Inc. · 1996
- Methods and means for the production of Ig-like molecules67US 9,248,182 B2Merus N.V. · 2016
- Bacteria-and fiber-containing composition for human gastrointestinal health66US 6,241,983 B1Metagenics, Inc. · 2001
- Methods and means for the production of Ig-like molecules66US 9,248,181 B2Merus N.V. · 2016